Stop Documenting.
Start Analyzing.

The pharmaceutical lifecycle is too complex for static documents. Krevyos transforms your regulatory, quality, and development processes into a unified, AI-ready data ecosystem.

The Hidden Costs of Document-First Pharma

Legacy systems weren't built for modern pharmaceutical complexity.

The Silo Effect

Your Development Scientists and Regulatory teams are working on the same product but speaking different languages. When data is locked in documents, collaboration dies.

The $1 Million Day

Launch delays aren't just frustrating; they are expensive. Inconsistencies between Module 3 and Quality Guidelines force rework that bleeds revenue daily.

The Integrity Gap

Scouring shared drives for the 'right version' isn't just inefficient—it's a compliance risk. Stop relying on human memory to maintain data integrity.

Imposing Simplicity on Complexity

One platform. Structured data. Complete traceability.

Single Source of Truth

Never copy-paste again. Whether it's an ICH guideline update or a change in formulation, input the data once. Krevyos propagates it everywhere—from R&D to the Health Authority application.

Automated Impact Analysis

Change is inevitable. Risk is optional. Our engine instantly visualizes how a modification in manufacturing impacts your regulatory filing, flagging inconsistencies before they become rejection letters.

AI-Ready Infrastructure

You cannot use AI on a PDF. Krevyos structures your raw data effectively, allowing predictive models to optimize your submissions. Don't just store your data—put it to work.

What's Document Chaos Costing You?

Calculate the annual cost of time your team spends searching for the right documents.

The Cost of Idle Time

Compliance Standards

Built for regulatory compliance from day one

ICH
ISO IDMP
21 CFR 11

Built For

Built for pharmaceutical teams ready to modernize

CMC TeamsQuality AssuranceRegulatory Affairs

Ready to Transform Your Workflows?

Join the early access program and be among the first to experience data-first pharmaceutical development.

Request Early Access